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Glutamate is the major excitatory neurotransmitter in the mammalian CNS and acts on both ionotropic and metabotropic glutamate
receptors (mGluRs). ThemGluRs are widely distributed in the CNS andmodulate a variety of neuronal processes, including neurotrans-
mitter release and ion channel function. In hippocampus and cortex, mGluR5 is highly expressed and plays an important role in the
regulation of synaptic plasticity. Calmodulin (CaM) binding dynamically regulates mGluR5 surface expression; however, the mecha-
nisms linking CaM tomGluR5 trafficking are not clear. Recent studies showed that CaM binding to mGluR7 regulates its trafficking in a
phosphorylation-dependent manner by disrupting the binding of protein interacting with C kinase 1. The E3 ligase seven in absentia
homolog (Siah)-1A binds to mGluR5 and competes with CaM binding, making it an intriguing molecule to regulate phosphorylation-
dependent trafficking of mGluR5. In the present study, we find that CaM competes with Siah-1A for mGluR5 binding in a
phosphorylation-dependentmanner in rat hippocampal neurons. Specifically, phosphorylation ofmGluR5 S901 favors Siah-1A binding
by displacing CaM. We identified critical residues regulating Siah-1A binding to mGluR5 and showed that binding is essential for the
Siah-1A effects on mGluR5 trafficking. Siah-1A binding decreases mGluR5 surface expression and increases endosomal trafficking and
lysosomal degradation of mGluR5. Thus CaM-regulated Siah-1A binding to mGluR5 dynamically regulates mGluR5 trafficking. These
findings support a conserved role for CaM in regulating mGluR trafficking by PKC-dependent regulation of receptor-binding proteins.
Introduction
Metabotropic glutamate receptors (mGluRs) exert neuromodula-
tory effects at the majority of excitatory synapses (Niswender and
Conn, 2010). The mGluRs (mGluR1–mGluR8) are G-protein-
coupled receptors (GPCRs), which are subdivided into three groups
based on agonist/antagonist selectivity, sequence homology, and
G-protein coupling. The group I mGluRs, mGluR1 and mGluR5,
couple to the Gq/11 family of G-proteins and activate phospholipase
C, leading to the production of diacylglycerol and inositol 1,4,5-
trisphosphate and release of intracellular calcium (Niswender and
Conn, 2010). mGluR5 modulates synaptic transmission and is in-
volved in activity-dependent short-term and long-term synaptic
plasticity (Lu¨scher andHuber, 2010). In addition,mGluR5has been
implicated in thepathophysiologyofmanyneurological andpsychi-
atric disorders, such as pain, anxiety, schizophrenia, drug addiction,
and Alzheimer’s disease (Krystal et al., 2010). Notably, overstimula-
tion ofmGluR5 is closely related to the pathophysiology of fragile X
mental retardation syndrome, indicating that mGluR5 may repre-
sent a potential pharmacologic target for the disease (Do¨len et al.,
2007).
Excitatory synapses are extremely dynamic and expression of
postsynaptic proteins is tightly regulated. In particular, the traf-
ficking of surface receptors can be rapidlymodified in response to
synaptic activity. As withmanyGPCRs,mGluR5 endocytosis and
intracellular sorting are important mechanisms for fine-tuning
mGluR5 signaling and preventing receptor overstimulation. The
surface expression of mGluR5 is dynamically regulated by cal-
modulin (CaM). Receptor activation triggers PKC phosphoryla-
tion of a critical residue on the mGluR5 C terminus, serine 901
(S901), which disrupts the binding of CaM to the receptor (Lee et
al., 2008). The result is increased internalization and decreased
surface expression. However, the underlying mechanism of
CaM-dependent mGluR5 trafficking is unknown.
CaM is a ubiquitously expressed calcium-binding protein
(Chin andMeans, 2000) particularly abundant in the brain. CaM
Received April 23, 2012; revised Sept. 18, 2012; accepted Sept. 22, 2012.
Author contributions: C.H.K. and K.R. designed research; S.J.K., K.I., I.K., J.H.L., H.J.C., S.Y.S., S.R.O., and S.P.
performed research; D.G.K., C.H.K., and K.R. analyzed data; C.H.K. and K.W.R. wrote the paper.
This workwas supported by Basic Science Research Program through the National Research Foundation of Korea
fundedby theMinistry of Education, Science, andTechnology (No. 2011-0003351and2011-0001174) (to C.H.K.), by
the Japan Society for the Promotion of Science Research Fellowship for Japanese Biomedical and Behavioral Re-
searchers at the National Institutes of Health (to K.I.) and by the National Institute of Neurological Disorders and
Stroke Intramural Research Program (to K.W.R.).We thank the Yonsei-Carl Zeiss Advanced Imaging Center at Yonsei
University College ofMedicine and Dr. Carolyn Smith at National Institute of Neurological Disorders and Stroke Light
Imaging Facility for technical assistance. The -tubulin monoclonal antibody developed by J. Frankel and E.M.
Nelsen was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the Na-
tional Institute of Child Health and Human Development and maintained by the University of Iowa, Department of
Biology, Iowa City, Iowa.
*S.J.K. and K.I. contributed equally to this work.
The authors declare no competing financial interests.
Correspondence should be addressed to Chul Hoon Kim, 134 Shinchon-dong, Seodaemun-gu, Seoul 120-752,
Korea. E-mail: kimhoon@yuhs.ac.
DOI:10.1523/JNEUROSCI.1964-12.2012
Copyright © 2012 the authors 0270-6474/12/3216391-11$15.00/0
The Journal of Neuroscience, November 14, 2012 • 32(46):16391–16401 • 16391
regulates the synaptic plasticity of excitatory synapses by forming
functional interactions with NMDA receptors and voltage-gated
calcium channels (Xia and Storm, 2005). Numerous neuronal
GPCRs, including dopamine, serotonin, opioid, and adenosine
receptors, have been reported to bind CaM (Wang et al., 1999;
Turner et al., 2004; Turner and Raymond, 2005; Navarro et al.,
2009). We recently showed that the surface expression of the
presynaptic mGluR7 receptor is dynamically regulated by PKC
phosphorylation and CaM binding (Suh et al., 2008). However,
for mGluR7, neuronal activities trigger dephosphorylation of the
major PKC phosphorylation site on the mGluR7 C terminus and
promote CaM binding. Like mGluR5, agonist stimulation of
mGluR7 leads to decreased surface expression. Interestingly,
CaM affects mGluR7 trafficking by competing with protein in-
teracting with C kinase 1 (PICK1) binding in a phosphorylation
state-dependent manner. However, mGluR5 does not bind to
PICK1, so the CaM binding to mGluR5must regulate trafficking
via a different set of protein interactions.
CaM competes with the E3 ligase seven in absentia homolog
(Siah)-1A for mGluR5 binding in vitro (Ishikawa et al., 1999),
and researchers have demonstrated that Siah-1A degrades
mGluR1 and mGluR5 (Moriyoshi et al., 2004). Because S901
phosphorylation regulates the interaction between CaM and
mGluR5 (Lee et al., 2008) and Siah-1A is present in synaptic
vesicles and endosomes (Wheeler et al., 2002), we hypothesized
that CaM-dependent regulation of mGluR5 trafficking could be
attributed to the competitive binding of CaM and Siah-1A. Here
we show that phosphorylation of mGluR5 displaces CaM and
enhances the interaction of Siah-1A with mGluR5, leading to
decreased levels of mGluR5 on the cell surface. We define critical
elements of the Siah-1A-binding site on themGluR5 C terminus,
which are distinct from the CaM-binding site. Using specificmu-
tations, we show that the direct interaction between Siah-1A and
mGluR5 is necessary for Siah-1A effects on receptor trafficking.
Furthermore, we investigate the role of Siah-1A in neurons and
find it specifically regulates mGluR5 expression. Together, these
results support a dynamic model in which activity-induced re-
ceptor phosphorylation regulates the trafficking of mGluRs
through receptor–CaM interactions.
Materials andMethods
Cell culture and transfection.HeLa cells were maintained in DMEM con-
taining 10% fetal bovine serum in 5% CO2/95% air at 37°C. The cells
were transfected with DNA constructs using Polyplus-transfection re-
agent (Polyplus-transfection) according to the manufacturer’s instruc-
tions. Primary hippocampal neuronal cell cultures were produced and
maintained according to the method described previously (Suh et al.,
2008) with some modifications. All experiments were performed in ac-
cordance with the Yonsei University College of Medicine Animal Care
and Use Committee or NIH Guide for the Care and Use of Laboratory
Animals. Briefly, primary hippocampal neuron cultures were prepared
from embryonic day 18 Sprague Dawley rat embryos of either sex. The
hippocampi were dissected, and the cells were dissociated by trituration
using a fine-bored Pasteur pipette. The cells were then plated onto cover
glasses coated with poly-L-lysine. The hippocampal cells were grown in
Neurobasal Medium (Invitrogen) supplemented with B-27 (2%) and
L-glutamine (2 mM). The cultures were maintained at 37°C in 5% CO2/
95% air.
Constructs and siRNA. We created the pCBA mammalian expression
vector using a chicken -actin promoter. mGluR5 cDNA was subcloned
into pCBA to produce pCBA-mGluR5. Site-directed mutagenesis was
performed using pCBA-mGluR5 as a template to make S901A, S901D,
T913D, I916A, and S901D/I916A mutants. A Myc epitope was inserted
between amino acids 22 and 23 of the N terminus of pRK5-mGluR5,
resulting in pRK5-N-Myc-mGluR5. Cam2 was subcloned into the
pcDNA3.1 and pPTuner-IRES vectors (Clontech). Siah-1A cDNA was
subcloned into the pCI-neo and pPTuner-IRES vectors. The cDNA en-
coding the first one-third of the C terminus (Cprox) of mGluR5 was
subcloned into the pGEX-4T1 (GE Health) and pBHA vectors. Siah-1A
was subcloned into the pRSET bacterial expression vector (Invitrogen)
and the pEGFP-C vector (Clontech). Yeast plasmids encoding mutant
forms of mGluR5 Cprox (S901A, S901D, T913A, T913D, V915A, I916A,
I916E, and P918A) were generated from pBHA-mGluR5 Cprox by site-
directed mutagenesis. The sequences of all mutants were confirmed by
sequencing. The human Siah-1A siRNA pool (L-012598-00-0050) was
purchased from Thermo Scientific, and human hepatocyte growth
factor-regulated tyrosine kinase substrate (Hrs) shRNA was purchased
from Sigma-Aldrich.
Western blot and immunoprecipitation.ForWestern blotting, cells were
washed twice with cold PBS and solubilized at 4°C for 15 min in PBS
containing 1% Triton X-100 and the Complete protease inhibitor mix-
ture (Roche). The cell lysates were then cleared by centrifugation at
12,000 g for 10 min at 4°C. The samples were resolved by SDS-PAGE
and transferred onto polyvinylidene fluoride membranes. The mem-
branes were blocked with 0.5% nonfat milk plus 0.1% Tween 20 for 2 h,
and protein levels were analyzed by immunoblotting with primary anti-
bodies, including mGluR5 (Epitomics), mGluR7 (Millipore), FLAGM2
(Sigma-Aldrich), Siah-1A (Abcam), CaM (Millipore), neomycin phos-
photransferase II (NPT-II, Millipore), -tubulin (Hybridoma Bank),
and -actin (Santa Cruz Biotechnology). For immunoprecipitation, the
lysates were homogenized and clarified by centrifugation at 12,000  g
for 10 min at 4°C. The supernatants were incubated with primary anti-
bodies overnight at 4°C, and the immune complexes were captured by
protein A agarose (GE Health) for 2 h at 4°C. The eluted immunopre-
cipitates from the protein A agarose were then subjected to Western
blotting.
Real-time quantitative PCR. The SYBR Green method was used for all
real-time quantitative PCR experiments. Reverse transcription was per-
formedwith 2g of total RNA using Superscript III reverse transcriptase
(Invitrogen). PCRs were subsequently established using 2 l of synthe-
sized cDNA, 250 nM primer pairs, and 10 l of SYBR Green PCRMaster
Mix (Applied Biosystems) in a total reaction volume of 20 l. The reac-
tions were run with the following cycling conditions: 10 min at 95°C,
then 40 cycles of 95°C for 20 s, 60°C for 40 s, and 70°C for 30 s. The values
were normalized to that of the housekeeping gene -actin.
Pull-down assay and PKC in vitro phosphorylation. The GST-mGluR5
Cprox fusion protein was purified using glutathione Sepharose 4B beads
according to the manufacturer’s instructions (GE Health). The GST-
mGluR5 Cprox bound to Sepharose beads was then incubated with ac-
tive PKC (25 ng, Promega) in a phosphorylation buffer containing 20mM
HEPES, 1.67 mM CaCl2, 1 mM DTT, 10 mM MgCl2, and 1 pmol of [-
32P]ATP (3000 Ci/mmol) at 30°C for 30 min. Phosphorylated fusion
proteins were incubated with purified CaM (Sigma-Aldrich) or the
Siah-1A His-fusion protein at 4°C for 2 h. The glutathione Sepharose 4B
beads were washed three times, and the bound proteins were eluted by
boiling in 2 SDS sample buffer for 5 min. The samples were then
analyzed by Western blotting with CaM or Siah-1A antibodies. PKC
phosphorylation ofmGluR5 S901was detected using the S901 phosphor-
ylation state-specific antibody described previously (Lee et al., 2008).
Biotinylation assay. HeLa cells transfected with mGluR5 wild-type
(WT), mutants, or Siah-1A were washed with PBS and incubated with
EZ-Link Sulfo-NHS-SS-Biotin (Pierce) in PBS for 20 min at 4°C. The
cells were washed three times with cold PBS with 50 mM glycine to
quench and remove excess biotin reagents. The cells were lysed with 1%
Triton X-100, and the lysates were cleared by centrifugation at 14,000
rpm for 10 min at 4°C. The supernatant was then incubated with Neu-
trAvidin agarose resin (Pierce) for 2 h at 4°C. The resin was washed four
times with PBS containing 1% Triton X-100, and the bound proteins
were eluted by mixing and incubating with 2 sample buffer at 37°C for
30 min. The eluted proteins were analyzed by Western blotting. For the
endocytosis assay, HeLa cells transfected with mGluR5 WT or mGluR5
S901A mutant were incubated with EZ-Link Sulfo-NHS-SS-Biotin in
PBS for 20min at 4°C. The cells were treatedwith glutamate (100M) for
5 min at 37°C and then the remaining biotinylated proteins on the cell
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surface were cleaved using 50mM reduced glutathione (Roche). After cell
lysis, NeutrAvidin agarose resin was added to the lysates for 2 h at 4°C.
After washing the resin, bound proteins were eluted and then subjected
to Western blotting.
Yeast two-hybrid assay. A yeast two-hybrid assay was performed using
the L40 yeast strain to detect the interaction between the mGluR5 C
terminus and Siah-1A. pBHA (LexA-DNA binding domain fusion
vector)-mGluR5 Cprox or its mutants and pGAD (GAL4-activation do-
main fusion vector)-Siah-1A were cotransformed into L40 yeast. The
yeasts were grown in synthetic completemedium lacking tryptophan and
leucine. Yeast colonies were picked up and dissolved in 10-fold serial
dilutions in sterile water in a 96-well plate. Using a replica plater, the
yeasts in each well were plated as a spot on a synthetic complete medium
agar plate lacking tryptophan, leucine, and histidine. The plates were
then placed in a 30°C incubator for 2–3 d.
Immunostaining for surface expression. HeLa cells grown on glass cov-
erslips were transfectedwithMyc-mGluR5 andGFP-Siah-1A. Live trans-
fected cells were washed once in ice-cold PBS and labeled with themouse
Myc (9E10) antibody (Sigma-Aldrich) for 15 min on ice. After three
washes in ice-cold PBS, the cells were fixedwith 4%paraformaldehyde in
PBS for 15min at room temperature and then permeabilized in PBSwith
0.25% Triton X-100 for 5 min. The coverslips were then incubated with
rabbit mGluR5 and chicken GFP antibodies (Invitrogen) for 30 min.
Following multiple washes with PBS, the cells were incubated with Alexa
488 anti-chicken, Alexa 568 anti-rabbit, and Alexa 647 anti-mouse sec-
ondary antibodies (Invitrogen) at 1:500 for 30 min. The coverslips were
washed and mounted with the ProLong Antifade Kit (Invitrogen). The
cells were visualized using a Zeiss LSM710 confocal microscope (Carl
Zeiss).
Primary cultured hippocampal neurons were transfected with EGFP
or Siah-1A-EGFP and surface receptor was monitored using a rabbit
mGluR5 N terminus antibody (Alomone). Alexa 568 anti-rabbit anti-
body was used as a secondary antibody. Images of EGFP-positive cells
were captured and mGluR5 fluorescence intensities were analyzed using
MetaMorph software (Molecular Devices).
Proximity ligation assay. The proximity ligation assay (PLA) was per-
formed using the Duolink assay kit (Olink Bioscience) according to the
manufacturer’s instructions. Primary cultured hippocampal neurons
grown on glass coverslips were fixed with 4% paraformaldehyde, perme-
abilized with 0.1% Triton X-100 in PBS, and incubated with the Duolink
blocking solution for 30 min at 37°C. A pair of mGluR5 and Siah-1A
antibodies was then loaded onto the cells in a humid chamber. After
overnight incubation at 4°C, the primary antibody solution was tapped
off from the coverslips. Afterwashing three timeswith PBS, the coverslips
were incubatedwith the PLA probe solution for 2 h and then subjected to
hybridization, ligation, and amplification. The cells were incubated with
detection solution in a preheated humid chamber for 60 min at 37°C.
After mounting, cells were visualized with the LSM710 confocal micro-
scope (Carl Zeiss). Serial optical sections at 0.22 m intervals were con-
verted to maximal projection. Quantification of confocal experiments
was performed using MetaMorph software (Molecular Devices). Ac-
quired images were thresholded, and the integrated intensities of
mGluR5–Siah-1 interaction in neurons were measured in 50 m den-
dritic segments. We evaluated dendritic fragments 50 m from the cell
bodies of each hippocampal neuron. The data were averaged from 150 to
200 dendritic fragments from at least six independent experiments.
Statistical analysis. All data are reported as means  SEM. Statistical
comparisons were made using two-tailed unpaired t test or one-way
ANOVA followed by Bonferroni-Dunn post hoc test for multiple com-
parisons as appropriate. Data were analyzed using Prism software
(GraphPad).
Results
A phosphomimetic mutation of S901 affects the stability
of mGluR5
Siah-1A is an E3 ligase that binds to the C terminus of mGluR5
(Fig. 1A) and regulates the stability of mGluR5. We have shown
previously that S901 phosphorylation inhibits the binding of
CaM to mGluR5 (Lee et al., 2008) (Fig. 1A). Because CaM com-
petes with Siah-1A for binding to group I mGluRs in vitro
(Ishikawa et al., 1999), we wanted to test whether the S901 phos-
phomimetic mutation (S901D) could also modulate Siah-1A
binding and therefore affect mGluR5 protein levels. We ex-
pressed mGluR5 (WT, S901D, or S901A) in HeLa cells and mea-
sured the protein expression levels by Western blotting using
anti-mGluR5 antibodies. The expression level of mGluR5 S901D
was low compared with mGluR5 WT and mGluR5 S901A (Fig.
1B). Importantly, the expression of NPT-II, which is encoded
from the same DNA construct containing mGluR5, was also
measured to confirm equal transfection ofDNA constructs. Real-
time PCR results indicated that the S901 mutations did not alter
mGluR5mRNA expression levels, which excluded the possibility
that the decreased expression of the mGluR5 S901D mutant was
due to reduced mGluR5 mRNA expression (Fig. 1C).
To assess whether the S901Dmutation affected the stability of
mGluR5, we performed a cycloheximide chase experiment and
measuredmGluR5degradation. Protein synthesis was blocked by
treatment with cycloheximide, and receptor expression levels
were monitored for 6 h. Compared with the half-life of mGluR5
WT, there was a significant decrease in the half-life of mGluR5
S901D, suggesting that the S901D mutation may accelerate the
degradation of mGluR5 as a result of diminished CaM and in-
creased Siah-1A binding to mGluR5 (Fig. 1D,E).
Siah-1A is required for the accelerated degradation of
mGluR5 S901D
To evaluate the role of Siah-1A binding in mGluR5 degradation,
HeLa cells were cotransfected with mGluR5 and Siah-1A, and
protein expression levels were measured by Western blotting.
Siah-1A overexpression reduced mGluR5 protein levels (Fig.
2A), but not mGluR7 (Fig. 2B), which is consistent with a previ-
ous report (Moriyoshi et al., 2004). We next compared the effect
of Siah-1A expression on mGluR5 WT and S901D levels. HeLa
cells were cotransfectedwith siRNA against Siah-1A andmGluR5
WT or mGluR5 S901D construct. In control samples, mGluR5
S901D was markedly decreased compared with mGluR5 WT
(Fig. 2C). However, when Siah-1A was knocked down with
siRNA, mGluR5 S901D was not significantly decreased com-
pared withmGluR5WT, revealing Siah-1A conferred differences
in mGluR5 stability between mGluR5 WT and mGluR5 S901D.
Considering previous data showing that mGluR5 S901D has
reduced CaM binding (Lee et al., 2008), we suspected that the
increased binding of Siah-1A to mGluR5 S901D would decrease
mGluR5 protein levels. To specifically examine whether the re-
duction in mGluR5 S901D protein levels was caused by the dif-
ferential binding of CaM and Siah-1A, we transfected cells with
mGluR5 WT or mGluR5 S901D. Receptor was immunoprecipi-
tated using the mGluR5 antibody, and immunoblotting was per-
formed using CaM and Siah-1A antibodies. The S901D mutant
showed a marked increase in Siah-1A binding and a significant
decrease in CaM binding (Fig. 2D). This suggests that the S901D
mutation favored Siah-1A over CaM binding, causing the S901D
mutant protein to be less stable than the mGluR5 WT protein.
Next, using an in vitro pull-down assay, we examined whether
Siah-1A bindingwas directly affected by S901 phosphorylation in
the absence of CaM. We discovered that CaM binding to the
mGluR5 Cprox GST-fusion protein is inhibited by PKC phos-
phorylation of S901; however, binding of purified Siah-1A in the
absence of CaM was not affected. These findings indicate that
Siah-1A binding was affected by the interaction with CaM and
not by the S901 phosphorylation status per se (Fig. 2E).
Ko, Isozaki et al. • Siah-1A and mGluR5 Trafficking J. Neurosci., November 14, 2012 • 32(46):16391–16401 • 16393
CaM and Siah-1A competition for
mGluR5 in situ
To investigate whether CaM and Siah-1A
compete for binding to mGluR5 in situ,
CaM and Siah-1A were cotransfected into
HeLa cells with mGluR5 WT. We found
that mGluR5 WT coimmunoprecipitated
with both endogenous CaM and Siah-1A
(Fig. 3A). CaM overexpression increased
binding of CaM to mGluR5 while de-
creasing the amount of Siah-1A binding.
Accordingly, Siah-1A overexpression in-
creased its binding to mGluR5, but de-
creased CaM binding, indicating that
CaM and Siah-1A antagonize one another
for mGluR5 binding in our cell system
(Fig. 3A).
To assess whether increased CaM
binding can regulate mGluR5 receptor
stability, which is dependent on Siah-1A
binding to the receptor, we used a CaM or
Siah-1A fused to a destabilization domain
(DD). The DD is responsible for the con-
stitutive and rapid degradation of fused
proteins (Banaszynski et al., 2006).
Shield1 is a reagent that binds to the DD
and protects the DD-fused protein from
degradation (Fig. 3B). We used this sys-
tem to sort out the possible trans effects
on promoters between DNA constructs,
which have long been known to be a con-
founding factor in cotransfection experi-
ments (Farr andRoman, 1992).HeLa cells
were cotransfected withmGluR5WTplus
CaM or Siah-1A DNA constructs fused to
the DD. In cells transfected with DD-
Siah-1A, Shield1 treatment increased the
expression of Siah-1A and decreased
mGluR5 protein levels (Fig. 3C, right),
which is consistent with the data from
our Siah-1A cDNA overexpression ex-
periment shown in Figure 2A. Impor-
tantly, upon treatment with Shield1,
CaM expression and the amount of
mGluR5 WT increased in cells trans-
fected with DD-CaM (Fig. 3C, left).
These results indicate that CaM and
Siah-1A compete with one another to
regulate mGluR5 stability.
CaM and Siah-1A interactions with
mGluR5 regulate receptor trafficking
To investigate whether mGluR5 regulation by CaM and
Siah-1A competition affects the cell surface expression of
mGluR5, we performed a biotinylation assay. Siah-1A and
mGluR5 WT were coexpressed in HeLa cells, and surface bi-
otinylation was performed followed by purification of biotin-
ylated proteins and Western blotting for mGluR5. We found
that Siah-1A decreased the amount of surface mGluR5, but
did not affect the level of mGluR7 surface expression (Fig.
4A). We next compared the surface expression of mGluR5
WT, S901D, and S901A. Similar to the Western blot data from
total cell lysates, the S901Dmutation reduced mGluR5 surface
expression compared with mGluR5 WT or mGluR5 S901A
(Fig. 4B, upper). The effects of Siah-1A on mGluR5 surface
expression could be mediated by changes in trafficking to ly-
sosomes and subsequent degradation. To test this hypothesis,
we treated cells with the lysosomal inhibitor chloroquine. In-
terestingly, we found that chloroquine treatment inhibited the
accelerated degradation of mGluR5 S901D, but the decrease in
mGluR5 S901D surface expression compared with mGluR5
WT was not affected, indicating that Siah-1A binding affects
surface expression of mGluR5 independent of receptor degra-
dation (Fig. 4B, lower).
Figure1. S901phosphomimeticmutationaffectsmGluR5proteinstability.A,SchematicfigureshowingcompetitionbetweenCaMand
Siah-1A for mGluR5 binding. Colored lines along amino acid sequences represent binding motifs for each protein. B, HeLa cells were
transfected with mGluR5 WT (S), S901D, or S901A mutants. mGluR5 expression levels were analyzed by Western blotting. NPT-II is ex-
pressed fromthe sameDNAconstruct as themGluR5gene (pCBA-mGluR5).NPT-II expressiondetectedby theNPT-II antibodywasusedas
an equal transfection control. The histogram represents blot quantification from at least four independent experiments. mGluR5 levels
werenormalized toNPT-II andexpressedas fold changesover thatof control cells expressingmGluR5WT.Data represent themeanvalues
(SEM).One-wayANOVA(F(2,12)13.41,p0.0009), followedbyBonferroni-Dunnposthoc test formultiplecomparisons.**p0.01
comparedwithmGluR5WT (S). C, Cells were transfectedwithmGluR5WT (S), S901D, or S901Amutants.mGluR5mRNA expressionwas
measuredusingquantitative real-timePCR.D, CellsexpressingWT(S),S901D,orS901Amutantswerepretreatedwithcycloheximide(200
g/ml) for 2 h and then collected at the indicated times. Proteins from cell lysates were separated by SDS-PAGE and analyzed by
Western blotting. E, mGluR5 band intensities in the chase experiment were plotted relative to those at the zero time point.
Data represent the mean values (SEM). One-way ANOVA (F(2,12) 121.5, p 0.0001), followed by Bonferroni-Dunn
post hoc test for multiple comparisons. **p 0.01 compared with mGluR5 WT (S).
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Because Siah-1A is an E3-ligase, we tested whether the E3-
ligase activity is required for the effect of Siah-1A on mGluR5
levels using the Siah-1A H59Y mutant devoid of the E3-ligase
activity. We found that the Siah-1A H59Y mutant did not affect
mGluR5 protein levels (Fig. 4C). We next
investigated the regulation of mGluR5
trafficking by Siah-1A by testing for a
potential interaction with Hrs. Hrs is
a key component of the ESCRT-0 com-
plex, which engages ubiquitinated cargo
proteins and sorts them to multivesicu-
lar endosomes, an essential step for
lysosomal degradation of membrane
proteins (Wollert et al., 2009). We per-
formed a coimmunoprecipitation assay
and demonstrated that mGluR5 binds to
Hrs in HeLa cells transfected with
mGluR5 WT and Hrs (Fig. 4D). mGluR5
S901Dboundmore toHrs comparedwith
mGluR5 WT (Fig. 4E), suggesting that
Hrs binding is also dependent on the
phosphorylation status of S901. We also
examined the effect of Hrs knockdown on
mGluR5 protein stability and discovered
that the stability ofmGluR5WT increased
after Hrs inhibition (Fig. 4F). Interest-
ingly, Hrs knockdown rescued the total
expression levels of mGluR5 S901D to al-
most mGluR5 WT levels, indicating that
Hrs is an important contributor to the re-
duced stability of the S901D mutant. To-
gether, these results provide evidence that
Siah-1A can regulate mGluR5 trafficking
through the endosomal pathway. Next,
we tested whether S901 phosphorylation
can initiate endocytosis because receptor
phosphorylation initiates receptor inter-
nalization in many GPCRs. Following a
short (5 min) treatment of glutamate, we
observed endocytosis of both mGluR5 WT
and S901A, suggesting that S901 phosphor-
ylationand subsequent changes inCaMand
Siah-1Abinding are not an absolute prereq-
uisite for triggering mGluR5 endocytosis
(Fig. 4G).
Defining the critical residues for Siah-
1A binding andmGluR5 trafficking
To complement our experiments on the
mGluR5 S901D mutant, which showed
changes in CaM binding but did not di-
rectly affect Siah-1A binding, we next
identified the amino acids important for
Siah-1A binding. We chose to focus on
residues that resembled the classic Siah-
1A-binding motif (Fig. 5A), which have
been reported previously (House et al.,
2003). Although mGluR5 was not in-
cluded in the list of proteins possessing a
Siah-1A-binding motif, similar and con-
served sequences are present in the
mGluR5 C terminus and overlap with the
reported Siah-1A-binding domain (Fig.
5A). Therefore, we made a series of point mutations within the
putative Siah-1A-binding region and performed yeast two-
hybrid assays. Interestingly, mutating isoleucine 916 (I916) to
alanine or aspartic acid completely disrupted Siah-1A binding to
Figure 2. Siah-1A regulation of mGluR5 stability. A, HeLa cells were transfected withmGluR5 and either a control vector or the Flag-
Siah-1Aconstruct.Westernblottingwasperformed todetect the levels ofmGluR5andSiah-1AusingmGluR5andFlagantibodies. Results
are the averages of at least four independent experiments. Unpaired t test (**p 0.01) versus mGluR5 WT (S). B, HeLa cells were
transfected with mGluR7 and either a control vector or the Flag-Siah-1A construct. Western blotting was performed. C, Cells expressing
mGluR5WT(S), S901D,orS901Amutantswere transfectedwithasiRNApoolagainstSiah-1A.Changes inmGluR5andSiah-1Aexpression
weredetectedbyWesternblotting.siCONTindicatesnontargetedcontrol siRNApool.D, Lysates fromthecells transfectedwithmGluR5WT
(S), S901D, or S901Amutantswere immunoprecipitatedwithmGluR5antibodies, andboundendogenous Siah-1AandCaMwere immu-
noblottedwiththeir respectiveantibodies.C,D,mGluR5levelswerenormalizedtoNPT-IIandexpressedasfoldchangesoverthatofcontrol
cellsexpressingmGluR5WT.Datarepresent themeanvalues(SEM).One-wayANOVA(C:F(2,12)22.50,p0.0001;D:F(2,9)536.6,
p0.0001), followedbyBonferroni-Dunnposthoc test formultiple comparisons. **p0.01 comparedwithmGluR5WT(S).E,mGluR5
CproxGST-fusionproteinswerephosphorylatedbyPKC, andaGSTpull-downassaywasperformed for CaMandSiah-1Abinding.mGluR5
Cprox GST-fusion proteins were incubated with purified CaM or Siah-1A, respectively, for binding reactions. The resulting blots were
visualized using S901phosphorylation state-specific, CaM, and Siah-1A antibodies.
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mGluR5 (Fig. 5B). According to a previous study (Tiedt et al.,
2001), a transcription coactivator, OBF-1, possesses a similar
Siah-1A-binding sequence to mGluR5, and mutating the hydro-
phobic amino acid (V, valine) to an acidic amino acid (E, glu-
tamic acid) drastically disrupted the Siah-1A interaction and
inhibited subsequent OBF-1 degradation. Consistent with this
report, the mGluR5 I916Emutant exhibited no Siah-1A binding.
The most conserved residue among the Siah-1A-binding pro-
teins is the last proline residue in the Siah-1A-binding motif, and
this residue is conserved in both group I mGluRs. However, mu-
tation of proline 918 (P918) to alanine had no effect on Siah-1A
binding to mGluR5 (Fig. 5B). In contrast, the phosphomimetic
mutation of mGluR5 threonine 913 (T913D) disrupted binding
with Siah-1A (Fig. 5B). We obtained similar results using a bio-
chemical assay analyzing coimmunopreciptation ofmGluR5 and
Siah-1A expressed in HeLa cells (Fig. 5C). These results demon-
strate that the Siah-1A-binding site is distinct from the CaM-
binding site, and hydrophobic interactions between Siah-1A and
mGluR5 are important for binding. Because we have not tested
the residues beyond the indicated region, there are possibly ad-
ditional residues that also contribute to binding.
To specifically examine the role of Siah-1A binding in the
regulation of mGluR5 surface expression, HeLa cells were trans-
fected with mGluR5 T913D or I916Amutants and subjected to a
biotinylation assay to monitor mGluR5 surface expression. The
two mutants that disrupted Siah-1A binding to mGluR5 showed
increased receptor surface expression (Fig. 5D). We next ana-
lyzed mGluR5 surface expression by immunostaining (Fig. 5E).
Here, we used GFP-fused Siah-1A to identify the transfected cells
and surface labelingwith theMyc antibody to detect cells express-
ingMyc-mGluR5 on the plasmamembrane.We observed almost
no surface expression of mGluR5 WT upon Siah-1A coexpres-
sion (Fig. 5E, top). In contrast, mGluR5 T913D and mGluR5
I916A were readily detected on the cell surface even in the cells
coexpressing Siah-1A (Fig. 5E, middle and bottom), which is
consistent with the results from the surface biotinylation assay
(Fig. 5D). Last, we tested the effect of the S901D and I916A dou-
ble mutation on mGluR5 surface expression. Interestingly,
mGluR5 S901D, I916A did not display decreased surface expres-
sion, consistent with Siah-1A binding being the critical factor
underlying the effects of the S901Dmutation onmGluR5 surface
expression (Fig. 5F). However, mGluR5 I916A did not increase
mGluR5 surface expression above that of mGluR5 WT, suggest-
ing that CaM binding and the I916A mutation act cooperatively
to inhibit Siah-1A binding to mGluR5 and to increase mGluR5
surface expression. Together, these results demonstrate that
Siah-1A binding is an important factor involved in the regulation
of mGluR5 surface trafficking.
Siah-1A binding regulates agonist-induced
mGluR5 trafficking
We next examined the effect of agonist-induced S901 phosphor-
ylation on mGluR5 surface expression. HeLa cells expressing
mGluR5 WT or mGluR5 S901A were treated with glutamate for
10 min, and a biotinylation assay was performed to monitor the
changes in mGluR5 surface expression. We previously showed
that glutamate-induced activation of mGluR5 induces the PKC
phosphorylation of S901 (Lee et al., 2008). In this study, gluta-
mate treatment decreased mGluR5 surface expression; however,
it did not decrease surfacemGluR5 S901A, which is not subject to
PKC phosphorylation (Fig. 6A). In addition, in the presence of
Siah-1A siRNA, the agonist-induced decrease in surface mGluR5
was blocked (Fig. 6B). These results support an important role
for Siah-1A in regulating mGluR5 trafficking following agonist-
stimulated mGluR5 S901 phosphorylation.
In situ detection of agonist-dependent
mGluR5–Siah-1A interaction
To assess whether competition between CaM and Siah-1A for
mGluR5 binding also occurs in primary cultured hippocampal
neurons, we studied mGluR5 and Siah-1A interactions in situ
using the Duolink PLA (see Materials andMethods). In brief, we
label neurons with CaM and Siah-1A antibodies and subse-
quently with species-specific secondary antibodies (so that each
secondary antibody specifically recognizes only 1 primary anti-
body). The secondary antibodies are attached to DNA strands
that participate in a series of reactions (ligation, replication, and
hybridization with fluorescently labeled detection oligonucleo-
tides) that can only occur when the two proteins are in close
proximity (40 nm). Therefore, PLA offers valuable in situ in-
formation about protein–protein interactions, although it is
semiquantitative due to limited dynamic range of detection. We
specifically monitored protein binding following agonist-
induced mGluR5 activation, which causes CaM displacement
due to S901 phosphorylation (Lee et al., 2008). First, we deter-
mined that Siah-1A interacts with mGluR5 in brain lysates (Fig.
7A) with an immunoprecipitation study. PLA probes for
mGluR5 and Siah-1A antibodies showed that the two proteins
interacted primarily along neurites and the cell body, which ap-
pear as fluorescent spots (Fig. 7B). These experiments reveal an
interaction betweenmGluR5 and Siah-1A within intact neurons.
Because 3,5-dihydroxyphenylglycine (DHPG), an mGluR5 ago-
Figure 3. Competition between CaM and Siah-1A for mGluR5 binding. A, HeLa cells were cotransfected with mGluR5 and either CaM or Siah-1A constructs. Immunoprecipitates from mGluR5
antibody incubation were immunoblotted using CaM or Siah-1A antibodies. B, DD was fused to the N terminus of CaM and Siah-1A. Upon treatment of Shield1, the stability of CaM and Siah-1A
increased, and rapid regulation of protein levels was achieved at the post-translational level. C, HeLa cells were cotransfected with mGluR5 DNA construct and the DD-linked CaM or Siah-1A DNA
construct. Shield1 was added to medium for 3 h (CaM) or 5 h (Siah-1A). Changes in mGluR5, CaM, and Siah-1A levels were measured by Western blotting.
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Figure 4. Siah-1A regulation of mGluR5 surface trafficking. A, HeLa cells were transfected with mGluR5 with or without Siah-1A. Surface expression of mGluR5 was analyzed by a
biotinylation assay. Biotinylated fractions were immunoblotted with mGluR5 antibodies. The same experiment was performed for mGluR7 using mGluR7 antibodies. B, Biotinylation
assays were performed in cells transfected with mGluR5WT (S), S901D, or S901Amutants in the absence or presence of chloroquine (25M) for 6 h. Purified biotinylated surface proteins
or total cell lysates were immunoblotted using mGluR5 antibodies. Quantitative measurement of mGluR5 levels from biotinylated surface proteins and total cell lysates (right). mGluR5
surface expression were normalized to NPT-II and expressed as fold changes over that of control cells expressing mGluR5 WT. Data represent the mean values (SEM). One-way ANOVA
[surface/chloroquine (): F(2,9) 198.1, p 0.0001; total/chloroquine (): F(2,9) 52.68, p 0.0001; surface/chloroquine (): F(2,9) 49.26, p 0.0001; total/chloroquine ():
F(2,9) 0.9102, p 0.4365], followed by Bonferroni-Dunn post hoc test for multiple comparisons. **p 0.01 comparedwithmGluR5WT (S). C, HeLa cells were transfected withmGluR5
and/or Siah-1A-H59Y mutant. Western blotting was performed to monitor mGluR5 protein levels. D, Lysates from HeLa cells cotransfected with mGluR5 and Hrs were subjected to
immunoprecipitation assays. Arrowhead indicates the band representing Hrs. E, HeLa cells were cotransfected with Hrs and mGluR5 WT or mGluR5 S901D. Immunoprecipitates isolated
with mGluR5 antibody were subjected to Western blotting with Hrs antibody. F, mGluR5 WT or S901D mutant was cotransfected into HeLa cells with control shRNA (nontargeted shRNA)
or shRNA against Hrs. mGluR5 levels were measured by Western blotting. One-way ANOVA (F(3,12)  36.85, p  0.0001), followed by Bonferroni-Dunn post hoc test for multiple
comparisons. *p 0.05 compared with mGluR5 WT (S) with nontargeted shRNA and **p 0.01 compared with mGluR5 S901D with nontargeted shRNA. G, HeLa cells were transfected
with mGluR5 WT or mGluR5 S901A. Cells were biotinylated and then treated with glutamate (100M) for 5 min. Remaining biotinylated mGluR5 was cleaved by reduced glutathione to
detect internalized biotinylated mGluR5.
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nist, was shown to induce phosphorylation of mGluR5 S901 in a
PKC-dependent manner (Lee et al., 2008), we treated neurons
with DHPG for 15 min and then subjected them to PLA. Com-
pared with no treatment, the fluorescent spots representing the
interaction between mGluR5 and Siah-1A were increased upon
treatment of DHPG (Fig. 7B,C), indicating that dynamic inter-
action of Siah-1A with mGluR5 is an event that occurs upon
mGluR5 activation in neuronal cells.
Siah-1A-mediated regulation of mGluR5 trafficking in
hippocampal neurons
To evaluate the effect of Siah-1A on mGluR5 trafficking in pri-
mary cultured hippocampal neurons, we transfected neurons
with EGFP or Siah-1A-EGFP. Cell surface expression of mGluR5
was detected using an mGluR5 antibody directed against the
mGluR5 extracellular domain (amino acids 367–380 of rat
mGluR5). The mGluR5 signal specificity was confirmed by ob-
Figure 5. Mutations disrupting Siah-1A-mGluR5 binding affect mGluR5 trafficking. A, Sequence of a portion of the mGluR5 C terminus containing critical binding domains (889–918; CaM-
bindingdomain889–917andSiah-1A-bindingdomain892–918). The Siah-1A-binding consensus sequence (PXAXVXP, X any aminoacid) is indicated at the top. Arrows indicate S901, T913, and
I916 on mGluR5. B, mGluR5 T913D, mGluR5 I916A, and mGluR5 I916E did not interact with Siah-1A in yeast two-hybrid assays. Yeasts were cotransformed with LexA-mGluR5 (828–944) (WT,
S901A, S901D, T913A, T913D,V915A, I916A, I916E, or P918A) andGal4-Siah-1A, andgrowthwas evaluated. Results shownare10-fold serial dilutions of yeast cells. All data shownare representative
of at least three independent experiments. C, HeLa cells were cotransfected withmGluR5WT,mGluR5 T913D, or mGluR5 I916A and subjected to a coimmunoprecipitation assay.D, HeLa cells were
transfected with mGluR5 WT, T913D, or I916A mutants. Surface expression levels of mGluR5 and its mutants were measured by a surface biotinylation assay. mGluR5 surface expression was
quantified bymeasuring the band intensity of mGluR5 and normalized to NPT-II expression. Data represent themean values (SEM). One-way ANOVA (F(2,12) 174.5, p 0.0001), followed by
Bonferroni-Dunnpost hoc test formultiple comparisons. **p0.01 comparedwithmGluR5WT (S).E, Cell surface labeling ofmGluR5WT, T913D, or I916A inHeLa cells. LiveHeLa cells cotransfected
with GFP-Siah-1A and Myc-mGluR5 WT, T913D, and I916A were labeled with mouse anti-Myc antibodies (surface) and Alexa 647-conjugated secondary antibodies (shown as white). After
permeabilization, the cellswere labeledwith rabbit anti-mGluR5antibodies (total) andAlexa 568-conjugated secondary antibodies (red). GFP-Siah-1Awas labeledwith chicken anti-GFP antibodies
and Alexa 488-conjugated secondary antibodies (green). F, HeLa cells were transfected with mGluR5 WT, mGluR5 S901D, or mGluR5 S901D and I916A double mutants. A biotinylation assay was
performed forWT andmutant mGluR5 surface expression. Data represent themean values (SEM). One-way ANOVA (F(2,12) 53.60, p 0.0001), followed by Bonferroni-Dunn post hoc test for
multiple comparisons. **p 0.01 compared with mGluR5WT (S).
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serving signal loss when the cells were preincubated with a con-
trol peptide corresponding to amino acids 367–380 of rat
mGluR5 (data not shown). Siah-1A decreased the mGluR5 fluo-
rescent cell surface signal compared with the control (Fig. 8A,B),
indicating that Siah-1A can regulate mGluR5 trafficking in hip-
pocampal neurons.
Discussion
A large number of mGluR5 binding proteins have been identi-
fied, including CaM and Siah-1A. An in vitro binding assay using
mGluR5 C-terminal fusion proteins first showed that CaM and
Siah-1A interact with mGluR5 in a mutually exclusive way
(Ishikawa et al., 1999). However, the relevance of this interaction
in situ and in neurons and the molecular events that affect the
binding activities have not yet been elucidated. The phosphory-
lation of mGluR5 S901 was the first example of dynamic regula-
tion of CaM binding to mGluR5 leading
to alterations in the receptor trafficking
(Lee et al., 2008). Because the amino acid
sequences for CaM and Siah-1A binding
overlap considerably (Fig. 1A), we pre-
dicted that S901 phosphorylation might
also affect Siah-1A binding to mGluR5.
Using several assays, we have now shown
that PKC phosphorylation enhances
Siah-1Abinding.However, using an in vitro
pull-down assay, we demonstrated that
S901phosphorylation inhibited the binding
of CaM, but did not affect Siah-1A binding
in the absence of CaM. This suggests that
CaM binding itself plays a central role in
regulating interactions between mGluR5
and Siah-1A and is the necessary protein
to modulate phosphorylation-dependent
Siah-1A effects. We tested this hypothesis
using a variety of approaches, and indeed
found that PKC phosphorylation of
mGluR5onS901dramatically affects recep-
tor traffickingand lysosomaldegradationby
promoting Siah-1A binding.We also define
the critical residues within the Siah-1A-
binding site and show that PKC phosphor-
ylation effects on trafficking are exquisitely sensitive to Siah-1A
binding.
Recently, norbin, which is another mGluR5-binding protein
and is involved in the development of schizophrenic phenotypes
in mice, has been reported to compete with CaM for mGluR5
binding (Wang et al., 2009). Interestingly, the binding motif for
norbin on themGluR5C terminus highly overlapswith theCaM-
binding site (Wang et al., 2009). Thus, it is likely that S901 phos-
phorylation also regulates norbin binding by modulating the
interaction of CaM with mGluR5, which would provide another
example of CaM regulating an mGluR5-binding protein. Similar
competitive binding has been reported with other GPCRs. For
example, CaM competes with G-proteins for binding to the
-opioid receptor (Wang et al., 1999). It also antagonizes PKC
Figure6. Effect of Siah-1Aonagonist-induced changes inmGluR5 surface expression.A, HeLa cells expressingmGluR5WTormGluR5S901Awere stimulatedwithglutamate (100M) for 10min,
and the lysates were subjected to a surface biotinylation assay. Data in the histogram represent themean values (SEM). One-way ANOVA (F(3,12) 41.64, p 0.0001), followed by Bonferroni-
Dunn post hoc test for multiple comparisons. **p 0.01 compared with mGluR5 WT (S) without glutamate. B, HeLa cells treated with siCONT (nontargeted siRNA pool) or siSiah-1A (siRNA pool
against Siah-1A) were transfected with mGluR5 and stimulated with glutamate (100M) for 10 min. Cell lysates were subject to a surface biotinylation assay. Data in the histogram represent the
mean values (SEM). One-way ANOVA (F(3,12) 72.06, p 0.0001), followed by Bonferroni-Dunn post hoc test for multiple comparisons. **p 0.01 compared with mGluR5 WT (S) without
glutamate. In A and B, mGluR5 biotinylation levels were normalized to NPT-II and expressed as fold changes over that of control cells expressing mGluR5WT.
Figure 7. mGluR5 and Siah-1A interaction in neurons. A, The hippocampus was isolated from rat brains. Total hippocampal
lysateswere subjected to immunoprecipitationwithmGluR5 antibodies and immunoblottingwith Siah-1A antibodies.We immu-
noblotted 10% input of brain lysateswith Siah-1A antibody.B, An in situPLAwas performedusingmGluR5 and Siah-1A antibodies
in primary cultured hippocampal neurons at 14 DIV in the absence or presence of DHPG (100M). C, Quantification of experiments
shown inB. Datawere averaged from 150 to 200 dendritic fragments from at least six independent experiments and expressed as
the mean SEM. Unpaired t test (**p 0.01) versus no treatment control.
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binding to 5-HT1A and 5-HT2A (Turner et
al., 2004; Turner and Raymond, 2005). In
contrast, CaM can also function to stabilize
the interaction of binding proteins to
GPCRs. For example, the 5-HT2C and
-arrestin complex is stabilized by CaM
(Labasqueet al., 2008).Together, these find-
ings indicate that CaM may act as a pan-
regulator of GPCR function by enhancing
or displacing GPCR-binding proteins.
The group III mGluR mGluR7 also
binds to CaM. However, in contrast to
mGluR5, CaMdissociation frommGluR7
promotes its trafficking to the cell surface
(Suh et al., 2008). Because Siah-1A does
not bind to mGluR7 (Moriyoshi et al.,
2004), it is plausible to assume that other
CaM-competing mGluR7-binding pro-
teins may inversely affect the distribution
of mGluR7 (Suh et al., 2008). Indeed, the mGluR7-binding pro-
tein PICK1 competes with CaM for receptor binding and in-
creases the surface expression of mGluR7. PICK1 is also
interesting because it binds to the extreme C terminus of
mGluR7, which is far from the CaM-binding domain, indicating
that the competition between CaM and other binding proteins is
not only relevant for two proteins with overlapping binding sites.
Together, these studies also support the notion that CaM can
modulate receptor function indirectly by regulating other
receptor-binding proteins, as seen with Siah-1A, which directly
impacts mGluR5 trafficking.
One important question is how Siah-1A regulates mGluR5
trafficking. Siah-1A functions as an E3 ligase for the group I
mGluRs (mGluR1 and mGluR5), as it promotes the ubiquitina-
tion of the receptor (Moriyoshi et al., 2004). The degradation of a
number of GPCRs occurs via lysosomal sorting, and the covalent
attachment of ubiquitin to the receptor can initiate this process
(Hanyaloglu and von Zastrow, 2008). Receptor ubiquitination is
also involved in initiating receptor endocytosis. For example, the
Cbl family of ubiquitin ligases mediates the ubiquitination of
epidermal growth factor receptor, which is essential for both re-
ceptor endocytosis and translocation to lysosomes for degrada-
tion (Haglund et al., 2003a; Mosesson et al., 2003). In our study,
enhanced degradation of mGluR5 S901D compared with
mGluR5WTwas a consequence of enhanced Siah-1A binding to
mGluR5. However, a lysosomal inhibitor selectively reversed the
decrease in total mGluR5 S901D protein levels, but not surface
mGluR5 S901D, consistent with Siah-1A actively regulating par-
ticular steps in the endocytic or lysosomal sorting pathways.
Siah-1A is responsible for both monoubiquitination and
polyubiquitination (Rott et al., 2008;Winter et al., 2008). Gener-
ally, polyubiquitination signals proteasomal degradation, and
monoubiquitination signals receptor sorting to late endosomes
and subsequent lysosomal degradation (Haglund et al., 2003b). A
GPCR, like mGluR5, undergoes endocytosis and enters into an
early endosome, where it will either recycle back to the mem-
brane or sort into the late endosomal/lysosomal pathway for deg-
radation. In our model, Siah-1A binding to mGluR5 would
trigger monoubiquitination of the receptor and target the recep-
tor into the late endosomal/lysosomal pathway. This model is
further supported by our demonstration of an interaction be-
tween Siah-1A andHrs and increased stability of mGluR5 by Hrs
deletion. These findings are consistent with Siah-1A binding to
mGluR5 and sorting the receptor into the lysosomal trafficking
pathway.
mGluR5 plays important roles in both synaptic plasticity and
neuronal development. For many glutamate receptors, such as
NMDA, AMPA, kainate, and metabotropic glutamate receptors,
which are involved in the regulation of synaptic plasticity, two
events are essential for regulating synaptic strength: receptor-
induced increases in intracellular calcium levels and phosphory-
lation of the glutamate receptors (Chen and Roche, 2007; Kim et
al., 2008). mGluR5 also appears to be subject to these two impor-
tant processes: mGluR5-induced calcium release results in CaM
activation, which is a calcium-sensor protein, and PKC-
dependent phosphorylation of residue S901 occurs after receptor
activation (Kim et al., 2005; Lee et al., 2008). Interestingly,
mGluR5 activation could initiate two potentially conflicting
events. mGluR5-induced calcium release enhances CaM binding
to mGluR5; however, mGluR5 activation-induced PKC phos-
phorylation of S901 displaces CaM. In our experimental model,
when mGluR5 was solely activated in heterologous cells and pri-
mary cultured hippocampal neurons, S901 phosphorylation ap-
peared to circumvent the potentially enhanced CaM affinity, as
mGluR5 activation decreased stabilization ofmGluR5 on the sur-
face and enhanced Siah-1A binding to mGluR5. However, under
in vivo conditions, numerous brain channels and receptors exist
that could increase intracellular free calcium and/or activate pro-
tein kinases/phosphatases and could be activated together or se-
quentially in distinct contexts for synaptic transmission and
plasticity. Thus, different synaptic transmission stages or modes
may confer varied receptor-binding capacities for CaM, which
would affect the ultimate effects on mGluR5 trafficking. These
seemingly contradictory regulatorymechanisms for theCaMand
mGluR5 interactions, when reconciled, could place CaM in a
central role for the integration of various synaptic signals.
Strict control ofmGluR5 activity is critical for preventing neu-
rological and psychological diseases. mGluR5 reduction or
knock-out has been shown to suppress anxiety and depression. In
fragile X mental retardation disease, uncontrolled mGluR5 sig-
naling due to the absence of the fragile X mental retardation
protein is considered the primary pathological mechanism
(Krueger andBear, 2011). Recently, the deletion of norbin, which
has CaM-like positive effects on mGluR5 surface expression and
signaling, was reported to aggravate schizophrenic symptoms in
animal models (Wang et al., 2009). Considering these results,
fine-tuning of synaptic receptor signaling is critical for normal
Figure8. Siah-1AdecreasedmGluR5 surfaceexpression inprimary culturedhippocampalneurons. Primary culturedhippocam-
pal neurons were transfected with EGFP or Siah-1A-EGFP. A, mGluR5 surface expression was visualized with rabbit mGluR5 N
terminus antibodies followed by Alexa 568-conjugated anti-rabbit secondary antibodies (red fluorescent signals), in the absence
or presence of Siah-1A-EGFP expression. B, Acquired images were thresholded, and the integrated mGluR5 immunostaining
intensities in neurons weremeasured in 20mdendritic segments close to the first branch point. The intensities of mGluR5were
quantified using MetaMorph software (Molecular Devices). Unpaired t test (**p 0.01) versus EGFP control. Images were taken
from50 neurons from four independent experiments.
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brain function. In the current study, CaM–Siah-1A interactions
were shown to be important for the regulation of neuronal
mGluR5 trafficking by controlling the number of receptors on
the cell surface. However, it remains to be determined why neu-
rons use CaM indirectly tomodulate the binding efficacy of other
mGluR5-binding proteins rather than directly regulating each
protein through receptor modifications, such as phosphoryla-
tion. Future studies to address this question will greatly enhance
our understanding of GPCR functions and the pathophysiology
of mGluR5-related diseases in the CNS.
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